2024
Switching Platelet P2Y12 Receptor Inhibiting Therapies.
Interventional cardiology clinics
鈥�Treats Adults
Fabiana Rollini, MBChB (MD)
Cardiologist
- Additional languages:
- Italian,
- French
(904) 383-1011
Request appointment online
Research at a glance
Research activity
My publications
Filter publications
129 publications
2024
Therapeutic Potential of FXI Inhibitors: Hype or Hope?
Drugs
鈥�2024
Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD.
JACC. Basic to translational science
鈥�2024
P2Y12 Inhibition in Patients Requiring Oral聽Anticoagulation After Percutaneous聽Coronary Intervention: The SWAP-AC-2 Study.
JACC. Cardiovascular interventions
鈥�2024
Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
Thrombosis and haemostasis
鈥�